Drugs
Conditions
News and resources
MIMS Supported ResourcesNICE approval for oral fibroid treatment
Ryeqo (relugolix/estradiol/norethisterone) is now a recommended option for treating moderate to severe symptoms of uterine fibroids within the NHS.
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.